Parkinson's Disease Drug Study- IRB H-28452
We are conducting a multicenter randomized clinical trial to evaluate the safety and effectiveness of Inosine in slowing the progression of Parkinson’s disease.
If you have any of the following:
· Tremors or shaking
· Slowed movements
· Small handwriting
· Stiffness
· Poor balance or problems walking
All of these may be symptoms of Parkinson’s disease.
You may qualify for this PD drug study if you:
· Have a diagnosis of Parkinson’s within the last 3 years or if you are experiencing some of the above symptoms
· Not on any PD medications other than rasagiline (Azilect) or selegiline (Deprynl)
· Do not have a history of gout or kidney stones
Eligible participants will receive study-related evaluations, laboratory tests, and the investigational drug at no cost. For more information about this study, please contact:
Boston University Medical Center Parkinson’s Disease and Movement Disorder Center at 617-638-7737 or 617-638-7745.